The Immuno-Oncology Drugs Market Growth Is Accelerated By Adoption Of Combination Therapies

https://www.coherentmarketinsights.com/market-insight/immuno-oncology-drugs-market-1271
Immuno-Oncology Drugs Market  


Immuno-oncology drugs target key pathways of the immune system to help the body naturally fight cancer. These drugs help T cells and other immune system cells identify and attack cancer cells more effectively. Targeted immunotherapies such as immune checkpoint inhibitors, cancer vaccines, and cellular therapies have shown promising results in the treatment of various cancers including melanoma, lung cancer and lymphoma.

The global Immuno-Oncology Drugs Market is estimated to be valued at US$ 1020.24 Bn  in 2023 and is expected to exhibit a CAGR of 33.%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Combination therapies have emerged as a key trend in the immuno-oncology drugs market. Combining immunotherapies that target different mechanisms has shown benefits over monotherapy in clinical trials. For example, combining immune checkpoint inhibitors like anti-PD-1 and anti-CTLA-4 drugs helps counter the immune resistance pathways of cancer more effectively. Combining immunotherapies with other anticancer therapies such as chemotherapy, targeted therapy and radiation therapy is also gaining popularity. The synergies created improve efficacy and help overcome resistance. Major players are focusing on developing combination regimens of immuno-oncology drugs for conditions where monotherapies have limitations. This is expected to further drive the adoption of immuno-oncology drugs during the forecast period.

Segment Analysis
The global immuno-oncology drugs market is dominated by the monoclonal antibody segment. Monoclonal antibodies act as checkpoint inhibitors that help enhance the immune system's natural antitumor responses and have emerged as a promising treatment approach. Checkpoint inhibitors target immune checkpoints such as CTLA-4, PD-1, and PD-L1 that are present on certain types of immune cells including T-cells, B-cells, and macrophages. By blocking these immune checkpoints, the antibodies help boost the body's antitumor immune response. The use of monoclonal antibodies against immune checkpoints has achieved major success in clinical practice to treat various cancers.

Key Takeaways
The global Immuno-Oncology Drugs Market Share is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: The North American region currently dominates the global market due to the early adoption of advanced cancer therapies and presence of major market players in the region. However, the Asia Pacific region is expected to grow at the fastest rate due to improving access to healthcare facilities, rising awareness about cancer treatment options, and growing focus of international players in countries such as China and India.

Key players: Key players operating in the immuno-oncology drugs market are IBM Corporation (US), Oracle Corporation (US), Xerox Corporation (US), Nintex Limited (US), Source Code Technology Holdings Inc (US), Software AG (Germany), Appian (US), Pegasystems (US), Bizagi (UK), Newgen Software Technology, and Zoho. The market players are focusing on new product launches, acquisitions, and collaborations to expand their product portfolios and geographic presence. For instance, in March 2022, Oracle Corporation launched Oracle Cloud Infrastructure Observability and Management services to help customers monitor cloud environments.

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more